Advances in the diagnosis and treatment of patients with hemodialysis-associated hypertension

Xiaoqiang Ding,Jinbo Yu
DOI: https://doi.org/10.3877/cma.j.issn.2095-3216.2014.03.001
2014-01-01
Abstract:Hypertension affects the majority of hemodialysis patients and is a risk factor for mortality.However,accurate assessment of blood pressure for hemodialysis patients is difficult as the blood pressure changes periodically with the periodic change of dialysis cycle volume.Attention should be paid to the importance of blood pressure measuring at different time points for the evaluation of blood pressure in hemodialysis patients.The target of blood pressure control in hemodialysis patients should be based on specific conditions of the patients,especially the patients′volume status and cardiac function.The control and maintenance of patients′volume are key factors of the treatment.The choice of anti-hypertensive drugs should be made according to the different rates of drugs clearance by hemodialysis.Long-acting calcium channel blockers,angiotensin receptor blockers,andα/βreceptor blockers are important in the treatment of hemodialysis-associated hypertension.
What problem does this paper attempt to address?